For UK independent hospitals
NHS patients on your local waiting lists are going private, just not to you
Record NHS waits are driving the largest surge in self-pay demand in a generation. Hospitals without a specific acquisition strategy see only modest self-pay growth while those with one grow far faster.
Two minutes. Solva follows up with specific waitlist acquisition options.
- Low conversion rates from website visitors to self-pay enquiries
- Marketing spend not directly attributable to self-pay patient acquisition
- Anecdotal evidence of NHS patients going private, but no clear internal data to support it
- Competitors visibly advertising services specifically targeting NHS waitlist patients.
- Underutilised private hospital capacity and resources
- Inefficient marketing spend with poor ROI
- Stagnant or slow self-pay revenue growth, missing significant market opportunities
- Increased reliance on insured patients, making the business vulnerable to changes in PMI policies
- Perception of being out of touch with patient needs and market trends
- Loss of market share to more agile competitors
NHS waiting lists exceeded 7.6 million in 2024, driving record private healthcare demand. (NHS England, 2025)
Source: https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
Frequently asked questions
Why does this problem persist?
Record NHS waiting lists are driving the largest surge in private healthcare demand in a generation. Hospitals without a specific strategy to reach and convert NHS waitlist patients are missing the most significant commercial opportunity in the sector.
What is the cost of leaving it unaddressed?
Hospitals with an active NHS waitlist acquisition strategy are growing self-pay revenue at 15-20% per year. Those without are growing at 3-5%. (LaingBuisson, 2025)
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.